248 related articles for article (PubMed ID: 33406323)
1. Associations Between ADHD Medication Use in Pregnancy and Severe Malformations Based on Prenatal and Postnatal Diagnoses: A Danish Registry-Based Study.
Kolding L; Ehrenstein V; Pedersen L; Sandager P; Petersen OB; Uldbjerg N; Pedersen LH
J Clin Psychiatry; 2021 Jan; 82(1):. PubMed ID: 33406323
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study.
Kolding L; Ehrenstein V; Pedersen L; Sandager P; Petersen OB; Uldbjerg N; Pedersen LH
BJOG; 2021 Nov; 128(12):1949-1957. PubMed ID: 34036715
[TBL] [Abstract][Full Text] [Related]
3. Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium.
Huybrechts KF; Bröms G; Christensen LB; Einarsdóttir K; Engeland A; Furu K; Gissler M; Hernandez-Diaz S; Karlsson P; Karlstad Ø; Kieler H; Lahesmaa-Korpinen AM; Mogun H; Nørgaard M; Reutfors J; Sørensen HT; Zoega H; Bateman BT
JAMA Psychiatry; 2018 Feb; 75(2):167-175. PubMed ID: 29238795
[TBL] [Abstract][Full Text] [Related]
4. Use of ADHD medication during pregnancy from 1999 to 2010: a Danish register-based study.
Haervig KB; Mortensen LH; Hansen AV; Strandberg-Larsen K
Pharmacoepidemiol Drug Saf; 2014 May; 23(5):526-33. PubMed ID: 24590619
[TBL] [Abstract][Full Text] [Related]
5. First-trimester exposure to methylphenidate: a population-based cohort study.
Pottegård A; Hallas J; Andersen JT; Løkkegaard EC; Dideriksen D; Aagaard L; Damkier P
J Clin Psychiatry; 2014 Jan; 75(1):e88-93. PubMed ID: 24502866
[TBL] [Abstract][Full Text] [Related]
6. Metoclopramide in pregnancy and risk of major congenital malformations and fetal death.
Pasternak B; Svanström H; Mølgaard-Nielsen D; Melbye M; Hviid A
JAMA; 2013 Oct; 310(15):1601-11. PubMed ID: 24129464
[TBL] [Abstract][Full Text] [Related]
7. Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring.
Christensen J; Pedersen L; Sun Y; Dreier JW; Brikell I; Dalsgaard S
JAMA Netw Open; 2019 Jan; 2(1):e186606. PubMed ID: 30646190
[TBL] [Abstract][Full Text] [Related]
8. Nitrosatable drug exposure during pregnancy and risk of stillbirth.
Thomsen AML; Liew Z; Riis AH; Stayner LT; Ramlau-Hansen CH; Sigsgaard T; Olsen J
Pharmacoepidemiol Drug Saf; 2019 Sep; 28(9):1204-1210. PubMed ID: 31348585
[TBL] [Abstract][Full Text] [Related]
9. Methylphenidate in Pregnancy: A Multicenter, Prospective, Comparative, Observational Study.
Diav-Citrin O; Shechtman S; Arnon J; Wajnberg R; Borisch C; Beck E; Richardson JL; Bozzo P; Nulman I; Ornoy A
J Clin Psychiatry; 2016 Sep; 77(9):1176-1181. PubMed ID: 27232650
[TBL] [Abstract][Full Text] [Related]
10. Fetal safety of methylphenidate-A scoping review and meta analysis.
Koren G; Barer Y; Ornoy A
Reprod Toxicol; 2020 Apr; 93():230-234. PubMed ID: 32169555
[TBL] [Abstract][Full Text] [Related]
11. Risk of Major Malformations in Infants After First-Trimester Exposure to Stimulants: Results From the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications.
Szpunar MJ; Freeman MP; Kobylski LA; Rossa ET; Gaccione P; Chitayat D; Viguera AC; Cohen LS
J Clin Psychopharmacol; 2023 Jul-Aug 01; 43(4):326-332. PubMed ID: 37235505
[TBL] [Abstract][Full Text] [Related]
12. Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: A nationwide cohort study in Denmark and Sweden.
Ankarfeldt MZ; Petersen J; Andersen JT; Li H; Motsko SP; Fast T; Hede SM; Jimenez-Solem E
PLoS Med; 2021 Nov; 18(11):e1003851. PubMed ID: 34807906
[TBL] [Abstract][Full Text] [Related]
13. Perinatal Outcomes After Treatment With ADHD Medication During Pregnancy.
Nörby U; Winbladh B; Källén K
Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29127207
[TBL] [Abstract][Full Text] [Related]
14. Atomoxetine in Early Pregnancy and the Prevalence of Major Congenital Malformations: A Multinational Study.
Bröms G; Hernandez-Diaz S; Huybrechts KF; Bateman BT; Kristiansen EB; Einarsdóttir K; Engeland A; Furu K; Gissler M; Karlsson P; Klungsøyr K; Lahesmaa-Korpinen AM; Mogun H; Nørgaard M; Reutfors J; Sørensen HT; Zoega H; Kieler H
J Clin Psychiatry; 2023 Jan; 84(1):. PubMed ID: 36652686
[No Abstract] [Full Text] [Related]
15. Pharmacological Treatment of Attention Deficit Hyperactivity Disorder During Pregnancy and Lactation.
Ornoy A
Pharm Res; 2018 Feb; 35(3):46. PubMed ID: 29411149
[TBL] [Abstract][Full Text] [Related]
16. Exposure to attention deficit hyperactivity disorder medications during pregnancy.
Humphreys C; Garcia-Bournissen F; Ito S; Koren G
Can Fam Physician; 2007 Jul; 53(7):1153-5. PubMed ID: 17872810
[TBL] [Abstract][Full Text] [Related]
17. Maternal and neonatal outcomes after exposure to ADHD medication during pregnancy: A systematic review and meta-analysis.
Jiang HY; Zhang X; Jiang CM; Fu HB
Pharmacoepidemiol Drug Saf; 2019 Mar; 28(3):288-295. PubMed ID: 30585374
[TBL] [Abstract][Full Text] [Related]
18. Ciprofloxacin exposure and adverse pregnancy outcomes: A Danish nationwide cohort study.
Noergaard M; Gotfredsen DR; Sørensen AMS; Andersen JT
BJOG; 2022 Aug; 129(9):1503-1511. PubMed ID: 34954900
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Association Between Oral and Topical Terbinafine Use in Pregnancy and Risk of Major Malformations and Spontaneous Abortion.
Andersson NW; Thomsen SF; Andersen JT
JAMA Dermatol; 2020 Apr; 156(4):375-383. PubMed ID: 32129793
[TBL] [Abstract][Full Text] [Related]
20. Maternal antipsychotic use during pregnancy and congenital malformations.
Liu X; Kolding L; Momen N; Gasse C; Pedersen LH
Am J Obstet Gynecol MFM; 2023 Jun; 5(6):100950. PubMed ID: 37015311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
